ASYLIA THERAPEUTICS
Asylia Therapeutics is a biotech company focused on novel immune-modulating therapies for autoimmune, cancer, and infectious diseases. The company's platform centers on a drug pipeline capable of modulating antigen presentation to the immune system which has produced unprecedented anti-tumor responses across multiple cancer models. Asylia Therapeutics was founded in 2019 in Houston, Texas.
ASYLIA THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2019-01-01
Address:
Houston, Texas, United States
Country:
United States
Website Url:
http://www.asyliatx.com
Total Employee:
1+
Status:
Active
Total Funding:
22.69 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Wordpress Plugins Mobile Non Scaleable Content Nginx
Current Employees Featured
![]()
Founder
![]()
Investors List
Sporos Bioventures
Sporos Bioventures investment in Series A - Asylia Therapeutics
Official Site Inspections
http://www.asyliatx.com Semrush global rank: 5.9 M Semrush visits lastest month: 1.4 K
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
Loading ... 
